Name: UMIN ID:
Unique ID issued by UMIN | UMIN000025452 |
---|---|
Receipt number | R000029240 |
Scientific Title | Phase I clinical study of a WT1-W10 peptide immunotherapy combined with standard treatment against diffuse midline glioma (WT1-TR-DMG). |
Date of disclosure of the study information | 2017/01/04 |
Last modified on | 2019/07/01 11:32:11 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/12/28 09:41:18 | ||
2 | Update | 2019/07/01 11:32:11 | Recruitment status Date of IRB |